文献速递头颈部肿瘤放疗放疗物理与技术

针对性干预改善荷兰头颈癌放疗计划质量的短期与长期影响

Targeted Intervention to Improve the Quality of Head and Neck Radiation Therapy Treatment Planning in the Netherlands: Short and Long-Term Impact.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2019-07-12

该研究将同一例口咽癌头颈癌(HNC)勾画CT送至荷兰全部15家收治HNC的放疗中心,经共识确立靶区与危及器官(OAR)剂量目标后各中心制定计划,并通过讨论OAR保护、由OAR保护最佳的中心分享策略实施针对性干预。结果显示初始OAR剂量差异很大,干预后再次计划显著降低平均剂量与变异且3年内保持稳定,但临床上相关差异仍存在。

要点

  • 干预后对侧腮腺、对侧颌下腺及吞咽结构平均剂量显著下降且变异缩小。
  • 干预效果在1年和3年后仍稳定,但中心间剂量差异依然较大。
  • 全国放疗肿瘤学平台有助于制定和维持高质量计划规范。

核心结论

  • 尽管荷兰各中心已有多年HNC调强放疗经验,初始治疗计划的OAR剂量差异仍出乎意料地大。
  • 简单的针对性干预改善了OAR保护且效果持久,但相当大的剂量差异仍然存在,需进一步研究以理解并缩小这些差异。

研究设计与样本

  • 将一例口咽癌HNC病例的勾画CT发送至荷兰全部15家收治HNC的放疗中心,经共识确立计划靶区与OAR剂量目标后各中心制定治疗计划。
  • 针对性干预方式为讨论所有计划的OAR保护,并由OAR保护最佳的中心分享其计划策略。
  • 干预效果通过干预后半年对原病例重新计划(短期)及干预后1年和3年对新病例计划(长期)评估。

主要发现

  • 初始平均剂量:对侧腮腺22 Gy(范围15-31 Gy),对侧颌下腺35 Gy(18-49 Gy),联合吞咽结构37 Gy(20-46 Gy)。
  • 干预后重新计划显著降低平均剂量及变异:对侧腮腺18 Gy(14-22 Gy),对侧颌下腺28 Gy(17-45 Gy),联合吞咽结构29 Gy(18-39 Gy)。
  • 临床上相关差异仍然存在,且1年和3年后变异保持稳定。

关键数值与推荐

  • OAR平均剂量目标由共识确立,涉及对侧腮腺、对侧颌下腺和联合吞咽结构。
  • 干预后对侧腮腺平均剂量18 Gy(范围14-22 Gy)、对侧颌下腺28 Gy(17-45 Gy)、联合吞咽结构29 Gy(18-39 Gy)。

临床怎么用

  • 可借鉴以单例基准测试加同行策略分享的针对性干预方式,在全国或多中心层面缩小HNC调强放疗计划的OAR剂量差异。
  • 应依托全国放疗肿瘤学平台持续开发和维护高质量计划规范,并定期复评计划质量以维持干预效果。

局限性

  • 研究基于单一口咽癌病例的基准测试与重新计划,长期评估仅采用新病例计划。
  • 干预后OAR剂量差异仍然较大,其成因尚未阐明,需进一步工作理解并最小化这些差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To benchmark and improve, through means of a targeted intervention, the quality of intensity modulated radiation therapy treatment planning for locally advanced head and neck cancer (HNC) in the Netherlands. The short and long-term impact of this intervention was assessed. METHODS AND MATERIALS: A delineated computed tomography-scan of an oropharynx HNC case was sent to all 15 Dutch radiation therapy centers treating HNC. Aims for planning target volume and organ-at-risk (OAR) dosimetry were established by consensus. Each center generated a treatment plan. In a targeted intervention, OAR sparing of all plans was discussed, and centers with the best OAR sparing shared their planning strategies. Impact of the intervention was assessed by (1) short-term (half a year after intervention) replanning of the original case and (2) long-term (1 and 3 years after intervention) planning of new cases. RESULTS: Benchmarking revealed substantial difference in OAR doses. Initial mean doses were 22 Gy (range, 15-31 Gy), 35 Gy (18-49 Gy), and 37 Gy (20-46 Gy) for the contralateral parotid gland, contralateral submandibular gland, and combined swallowing structures, respectively. Replanning after targeted intervention significantly reduced mean doses and variation, but clinically relevant differences still remained: 18 Gy (14-22 Gy), 28 Gy (17-45 Gy), and 29 Gy (18-39 Gy), respectively. One and 3 years later the variation remained stable. CONCLUSIONS: Despite many years of HNC intensity modulated radiation therapy experience, initial treatment plans showed surprisingly large variations. The simple targeted intervention used in this analysis improved OAR sparing, and its impact was durable; however, fairly large dose differences still continue to exist. Additional work is needed to understand these variations and to minimize them. A national radiation oncology platform can be instrumental for developing and maintaining high-quality planning protocols.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Verbakel WFAR, Doornaert PAH, Raaijmakers CPJ, et al. Targeted Intervention to Improve the Quality of Head and Neck Radiation Therapy Treatment Planning in the Netherlands: Short and Long-Term Impact. Int J Radiat Oncol Biol Phys. 2019. PMID: 31306734. doi:10.1016/j.ijrobp.2019.07.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。